Latest News for: limb infarction

Edit

Late-Breaking Data at ACC.21 Show XARELTO® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in ...

The Trentonian 16 May 2021
The primary efficacy endpoint was a composite of major adverse limb and cardiovascular (CV) events, including acute limb ischemia, major amputation for vascular causes, heart attack (myocardial infarction), ischemic stroke, or death from CV causes.
Edit

Isreali Health Body Report on COVID Vax ‘Deadly’ Impacts

Principia Scientific 25 Apr 2021
I will outline just some of the most devastating findings presented in the report ... 5000 (1 ... It should be noted that a significant number of reports of side effects are related, directly or indirectly, to Hypercoagulability (infarction), Myocardial infarction, stroke, miscarriages, impaired blood flow to the limbs, pulmonary embolism.” ... See more here.
Edit

The Israeli People’s Committee – April Report on the LETHAL Impact of the Pfizer One

Tap News 24 Apr 2021
ER Editor ... A Big Pharma outfit gets to TARGET a particular group of people?. Which turns out to be Israel? ... It should be noted that a significant number of reports of side effects are related, directly or indirectly, to Hypercoagulabilit (infarction), Myocardial infarction, stroke, miscarriages, impaired blood flow to the limbs, pulmonary embolism.” ... .
photo: AP / Tsafrir Abayov
File - In this Jan. 7, 2021 file photo, an Israeli military paramedic prepares a Pfizer COVID-19 vaccine, to be administered to elderly people at a medical center in Ashdod, southern Israel.
Edit

The Israeli People Committee’s April Report on the lethal impact of vaccinations

WorldNews.com 23 Apr 2021
by Gilad Atzmon ... 5000 (1 ... 1600 at ages 70+) ... It should be noted that a significant number of reports of side effects are related, directly or indirectly, to Hypercoagulability (infarction), Myocardial infarction, stroke, miscarriages, impaired blood flow to the limbs, pulmonary embolism.” In Israel, the government is desperate to vaccinate children ... .
Edit

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO® (rivaroxaban) ...

The Trentonian 26 Oct 2020
The application is based on data from the study, which showed XARELTO® (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major cardiovascular (CV) and limb events, with similar rates of Thrombolysis In Myocardial Infarction (TIMI) major bleeding.
Edit

US Patent and Trademark Office Allows Reven’s Patent Application to Issue as a New Patent

The Marshall News Messenger 17 Sep 2020
GOLDEN, Colo.--(BUSINESS WIRE)--Sep 17, 2020-- ... The lead anti-inflammatory/anti-oxidant investigational drug product Rejuveinix (RJX) is being developed for both treatment of COVID-19 as well as chronic limb threatening ischemia (CLTI), a cardiovascular condition associated with a high risk of limb amputation, myocardial infarct and stroke ... CONTACT.
Edit

Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in ...

The Trentonian 28 Mar 2020
This is a particularly high-risk period for severe limb outcomes as well as bleeding," said Marc P ... The primary efficacy endpoint was a composite of major adverse limb and CV events, including acute limb ischemia, major amputation for vascular causes, heart attack (myocardial infarction), ischemic stroke, or death from CV causes.
Edit

Endonovo Therapeutics Reports Third Quarter 2019 Results

Dothan Eagle 19 Nov 2019
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB ... -- Further developments in studies and trials for additional medical indications including NASH, myocardial infarction, critical limb ischemia, chronic kidney disease, post-concussive syndrome and other studies are postponed until the Company becomes profitable ... Mr ... .
Edit

Those under 40 at risk of strokes too: doctors

The Hindu 06 Nov 2019
Doctors said the two patients — aged 32 and 34 — were presented with acute weakness of left upper and lower limb along with chest pain. They were diagnosed with myocardial infarction and acute stroke that needed immediate intervention through thrombolysis.
Edit

Hikma launches prefilled syringes in the US

Dothan Eagle 17 Sep 2019
These serious thromboembolic events include deep vein thrombosis, pulmonary embolism, cerebral vein thrombosis, limb ischemia, stroke, myocardial infarction, mesenteric thrombosis, renal arterial thrombosis, skin necrosis, gangrene of the extremities that may lead to amputation, and possibly death.
Edit

New drug for stroke, a first for Pudukkottai GMCH

Deccan Chronicle 27 May 2019
Meenakshi Sundaram, dean, GMCH said that the patient Rajkumar of Melur village had suffered left hemiplegic stroke on May 23, whereby the left upper and lower limb were paralysed in addition to difficulty in speech ... Dr Chinna Mariyappan, civil assistant surgeon, examined the patient and found the left upper limb and lower limb were paralyzed.
  • 1
×